Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter Prospective Long-term Registry of Pediatric Patients with Crohn's Disease or Ulcerative Colitis
2008-005237-30Phase 4Active
- Sponsor
- Janssen Biologics B.V.
- Start
- Aug 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in Crohn's disease, autoimmune colitis, sponsored by Janssen Biologics B.V.. Started Aug 2009; status: active.
02
Drugs
infliximab
03
Conditions
Crohn's diseaseautoimmune colitis
Beyond the preview
Go deeper on 2008-005237-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005237-30.